FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 02/25/2009 |
3. Issuer Name and Ticker or Trading Symbol
Cardiovascular Systems Inc [ CSII ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) 02/25/2009 |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 398,679 | I | Easton Hunt Capital Partners, L.P.(1) |
Common Stock | 398,679 | I | Easton Capital Partners, LP(1) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Warrant (Right to Buy) | 07/19/2006 | 07/19/2011 | Common Stock | 56,611 | $8.78 | I | Easton Hunt Capital Partners, L.P.(2) |
Warrant (Right to Buy) | 09/12/2008 | 09/12/2013 | Common Stock | 107,833 | $9.28 | I | Easton Hunt Capital Partners, L.P.(2) |
Warrant (Right to Buy) | 02/25/2009 | 02/24/2014 | Common Stock | 151,617 | $8.83 | I | Easton Hunt Capital Partners, L.P.(2) |
Warrant (Right to Buy) | 07/19/2006 | 07/19/2011 | Common Stock | 56,611 | $8.78 | I | Easton Capital Partners, LP(2) |
Warrant (Right to Buy) | 02/25/2009 | 02/24/2014 | Common Stock | 151,617 | $8.83 | I | Easton Capital Partners, LP(2) |
Explanation of Responses: |
1. This amendment adds shares held by Easton Hunt Capital Partners, L.P. and Easton Capital Partners, LP (collectively, "Easton") that were previously not included as being indirectly beneficially owned by Mr. Friedman on his original Form 3 filed on February 25, 2009. Investment decisions of Easton Hunt Capital Partners, L.P. are made by EHC GP, LP through its General Partner, EHC, Inc. Mr. Friedman is the President and Chief Executive Officer of EHC, Inc. Investment decisions of Easton Capital Partners, LP are made by its General Partner, ECP GP, LLC, through its manager ECP GP, Inc. Mr. Friedman is the President and Chief Executive Officer of EHC, Inc. and ECP GP, Inc. Mr. Friedman shares voting and investment power of the shares owned by Easton. Mr. Friedman disclaims beneficial ownership of securities held by Easton except to the extent of his pecuniary interest therein. |
2. This amendment adds warrants held by Easton that were previously not reported as being indirectly beneficially owned by Mr. Friedman on his original Form 3 filed on February 25, 2009. Mr. Friedman disclaims beneficial ownership of securities held by Easton except to the extent of his pecuniary interest therein. |
Remarks: |
/s/ Robert K. Ranum as Attorney-in-Fact for John H. Friedman pursuant to Power of Attorney previously filed. | 09/09/2011 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |